Chemours (NYSE: CC) reported Q2 EPS of $1.20, $0.28 better than the analyst estimate of $0.92. Revenue for the quarter came in at $1.7 billion versus the consensus estimate of $1.52 billion.

For earnings history and earnings-related data on Chemours (CC) click here.